Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02205021 |
|
Recruitment Status :
Completed
First Posted : July 31, 2014
Last Update Posted : July 31, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Obesity | Other: No intervention |
| Study Type : | Observational |
| Actual Enrollment : | 303 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Compartmental Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome |
| Study Start Date : | January 2014 |
| Actual Primary Completion Date : | March 2014 |
| Group/Cohort | Intervention/treatment |
|---|---|
| All subjects |
Other: No intervention |
- Relationship of specific neck compartments to cardiovascular risk [ Time Frame: 1 year between PET/CT and cardiometabolic marker measures ]Cardiovascular risk measures were obtained within one year of CT imaging of the neck.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 91 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- no history of malignancy at the time of image acquisition
- fasting glucose measured immediately prior to PET/CT
Exclusion Criteria:
- history of neck cancer, radiation therapy, and/or surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02205021
| United States, Massachusetts | |
| Massachusetts General Hospital | |
| Boston, Massachusetts, United States, 02114 | |
| Principal Investigator: | Martin Torriani, M.D. | Massachusetts General Hospital |
| Responsible Party: | Torriani, Martin,M.D., Assistant Professor of Radiology, Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT02205021 |
| Other Study ID Numbers: |
2012P001603 |
| First Posted: | July 31, 2014 Key Record Dates |
| Last Update Posted: | July 31, 2014 |
| Last Verified: | July 2014 |
|
Metabolic Syndrome Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |

